SCHEMBL2118121

SCHEMBL2118121

C[CH]CC#CCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2120750 0.75
SCHEMBL11667446 0.75
SCHEMBL1894280 0.73
SCHEMBL7109 0.73
SCHEMBL2123323 0.71
SCHEMBL7611815 0.71
SCHEMBL7368401 0.71
SCHEMBL367118 0.71
SCHEMBL292525 0.71
SCHEMBL3930825 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 337 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1917239-A1 FLUOROPROSTAGLANDINS NITRODERIVATIVES Pfizer, Inc. (US) 2008-05-07 EP claimed
WO-2007000642-A1 FLUOROPROSTAGLANDINS NITRODERIVATIVES PFIZER INC. (US) 2007-01-04 WO claimed
US-7015223-B1 Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION (US) 2006-03-21 US claimed
US-7015230-B1 Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION (US) 2006-03-21 US claimed
EP-1586565-A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade Pharmacia Corporation (US) 2005-10-19 EP claimed
US-20050165021-A1 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION (US) 2005-07-28 US claimed
US-20050165062-A1 Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION (US) 2005-07-28 US claimed
US-20050153965-A1 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION (US) 2005-07-14 US claimed
US-6906068-B1 Substituted polycyclic aryl and heteroaryl 1,2,4 - triazinones useful as anticoagulants PHARMACIA CORPORATION (US) 2005-06-14 US claimed
EP-1202975-B1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRAZINONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE PHARMACIA CORP (US) 2005-04-06 EP claimed
US-5416231-A Prostaglandin I2 derivatives ASAHI GLASS COMPANY, LTD. (JP) 1995-05-16 US claimed
US-5041559-A Having epoxy and silyl groups NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1991-08-20 US claimed
US-5037855-A Silane group containing, chemical intermediates NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1991-08-06 US claimed
EP-0171992-B1 PHARMACEUTICALS CONTAINING PROSTAGLANDIN I2 MITSUBISHI KASEI CORPORATION (JP) 1990-06-06 EP claimed
US-4902812-A Optically active alcohols, process for producing the same, and process for resolving the same NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1990-02-20 US claimed
US-4837342-A STABILITY SAGAMI CHEMICAL RESEARCH CENTER (JP) 1989-06-06 US claimed
US-4820836-A ANTICOAGULANTS, ANTIULCER AGENTS SHIONOGI & CO., LTD. (JP) 1989-04-11 US claimed
US-4699921-A CIRCULATION AMELIORATING AND ANTIULCER EFFECT MITSUBISHI YUKA PHARMACEUTICAL CO., LTD. (JP) 1987-10-13 US claimed
EP-0234576-A1 Prostacyclin analogue, and blood circulation improving agent and anti-ulcer composition containing it as active ingredient SAGAMI CHEMICAL RESEARCH CENTER (JP) 1987-09-02 EP claimed
EP-0171992-A2 Pharmaceuticals containing prostaglandin I2 MITSUBISHI KASEI CORPORATION (JP) 1986-02-19 EP claimed